Annual Total Expenses
$50.02 M
-$4.21 M-7.76%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual total expenses is $50.02 million, with the most recent change of -$4.21 million (-7.76%) on December 31, 2023.
- During the last 3 years, LVTX annual total expenses has risen by +$31.60 million (+171.56%).
- LVTX annual total expenses is now -7.76% below its all-time high of $54.23 million, reached on December 31, 2022.
Performance
LVTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$11.29 M
+$1.92 M+20.55%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly total expenses is $11.29 million, with the most recent change of +$1.92 million (+20.55%) on September 30, 2024.
- Over the past year, LVTX quarterly total expenses has increased by +$505.00 thousand (+4.68%).
- LVTX quarterly total expenses is now -44.79% below its all-time high of $20.44 million, reached on March 31, 2021.
Performance
LVTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
LVTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.8% | +4.7% |
| 3 y3 years | +171.6% | +4.7% |
| 5 y5 years | +422.0% | +4.7% |
LVTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.8% | +2.2% | -39.6% | +94.7% |
| 5 y | 5-year | -7.8% | +422.0% | -44.8% | +182.9% |
| alltime | all time | -7.8% | +422.0% | -44.8% | +182.9% |
LAVA Therapeutics NV Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.29 M(+20.6%) |
| Jun 2024 | - | $9.36 M(+4.7%) |
| Mar 2024 | - | $8.94 M(+54.3%) |
| Dec 2023 | $50.02 M(-7.8%) | $5.79 M(-46.2%) |
| Sep 2023 | - | $10.78 M(-42.3%) |
| Jun 2023 | - | $18.68 M(+26.6%) |
| Mar 2023 | - | $14.76 M(+4.6%) |
| Dec 2022 | $54.23 M | $14.12 M(-16.1%) |
| Sep 2022 | - | $16.83 M(+45.8%) |
| Jun 2022 | - | $11.54 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.73 M(+12.8%) |
| Dec 2021 | $48.96 M(+165.8%) | $10.40 M(-0.6%) |
| Sep 2021 | - | $10.46 M(+36.6%) |
| Jun 2021 | - | $7.66 M(-62.5%) |
| Mar 2021 | - | $20.44 M(+297.9%) |
| Dec 2020 | $18.42 M(+92.2%) | $5.14 M(+10.7%) |
| Sep 2020 | - | $4.64 M(+10.1%) |
| Jun 2020 | - | $4.21 M(+5.6%) |
| Mar 2020 | - | $3.99 M |
| Dec 2019 | $9.58 M | - |
FAQ
- What is LAVA Therapeutics NV annual total expenses?
- What is the all time high annual total expenses for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual total expenses year-on-year change?
- What is LAVA Therapeutics NV quarterly total expenses?
- What is the all time high quarterly total expenses for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly total expenses year-on-year change?
What is LAVA Therapeutics NV annual total expenses?
The current annual total expenses of LVTX is $50.02 M
What is the all time high annual total expenses for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual total expenses is $54.23 M
What is LAVA Therapeutics NV annual total expenses year-on-year change?
Over the past year, LVTX annual total expenses has changed by -$4.21 M (-7.76%)
What is LAVA Therapeutics NV quarterly total expenses?
The current quarterly total expenses of LVTX is $11.29 M
What is the all time high quarterly total expenses for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly total expenses is $20.44 M
What is LAVA Therapeutics NV quarterly total expenses year-on-year change?
Over the past year, LVTX quarterly total expenses has changed by +$505.00 K (+4.68%)